| 1 | Current Technologies for RNA-Directed Liquid Diagnostics. 2021;13:5060 doi: 10.3390/cancers13205060 |
| 2 | MicroRNA-199b Deregulation Shows Oncogenic Properties and Promising Clinical Value as Circulating Marker in Locally Advanced Rectal Cancer Patients. 2022;23:2203 doi: 10.3390/ijms23042203 |
| 3 | Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from
Diagnosis to Treatment. 2022;11:12 doi: 10.2174/2211536611666220322160242 |
| 4 |
Noncoding
RNAs
in oral cancer
. 2022; doi: 10.1002/wrna.1754 |
| 5 | Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors. 2021;13:5698 doi: 10.3390/cancers13225698 |
| 6 | Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. 2021;22:7913 doi: 10.3390/ijms22157913 |
| 7 | MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment. 2021;13:127 doi: 10.3390/cancers13010127 |
| 8 | Dietary stilbenes as modulators of specific miRNAs in prostate cancer. 2022;13: doi: 10.3389/fphar.2022.970280 |
| 9 | Potential utility of miRNAs for liquid biopsy in breast cancer. 2022;12: doi: 10.3389/fonc.2022.940314 |
Cancer Drug Resistance
